Sage Journals: Discover world-class research

Retricted access

Research article

First published 2004-5

HBL-3 Cell Line,Derived from Precursor B-cell Lymphoblastic Leukemia,Lacks Somatic Hypermutation of Immunoglobulin Heavy Chain Variable Region Genes

Hiroshi Hojo, Yoshikazu Sasaki, Naoya Nakamura [...]

Pediatric and Developmental Pathology

Retricted access

Research article

First published 2023-03

Alpha to Omicron (Variants of Concern): Mutation Journey,Vaccines,and Therapy

Mohamad Hamad, Dana M.H. AlKhamach, Lujain Majed Alsayadi [...]

Viral Immunology

Open access

Case report

First published 2020-6

Successful treatment of a patient with NSCLC carrying uncommon compound EGFR G719X and S768I mutations using osimertinib: A case report

Yangyang Cai, Yizhuo Wang, Jingnan Sun [...]

Journal of International Medical Research

Retricted access

Brief report

First published 2000-12

Delineation of the Spectrum of Wilson Disease Mutations in the Greek Population and the Identification of Six Novel Mutations

Georgios Loudianos, Mario Lovicu, Paola Solinas [...]

Genetic Testing and Molecular Biomarkers

Retricted access

Research article

First published 2018-1

An Atypical Presentation of Alagille Syndrome

Katherine Y Wu, Amanda L Treece, Pierre A Russo [...]

Pediatric and Developmental Pathology

Retricted access

Review article

First published 2021-3

Autosomal dominant retinitis pigmentosa with toxic gain of function: Mechanisms and therapeutics

Ishwarya Narasimhan, Aishwarya Murali, Krishnakumar Subramanian [...]

European Journal of Ophthalmology

Open access

Review article

First published 2020

Gilteritinib in the treatment of relapsed and refractory acute myeloid leukemia with a FLT3 mutation

Serena Chew, Melissa C. Mackey, Elias Jabbour

Therapeutic Advances in Hematology

Open access

Review article

First published 2023

Advances in the management of non-small-cell lung cancer harbouring EGFR exon 20 insertion mutations

Jia Li Low, Sun Min Lim, Jii Bum Lee [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2013-09

Surgical resection of locally advanced epidermal growth factor receptor (EGFR) mutated lung adenocarcinoma after gefitinib and review of the literature

Ilaria Marech, Angelo Vacca, Antonio Gnoni [...]

Tumori Journal

Retricted access

Review article

First published 2018-7

Osimertinib: A third-generation tyrosine kinase inhibitor for treatment of epidermal growth factor receptor-mutated non-small cell lung cancer with the acquired Thr790Met mutation

Meredith K Bollinger, Amanda S Agnew, Gerard P Mascara

Journal of Oncology Pharmacy Practice

Search results